Archive for March, 2006
Data From Novogen Inflammatory Bowel Disease Drug Phase I Clinical Trial Shows Promise
A recentlycompleted Phase 1 clinical trial of an investigational drug to treatinflammatory bowel disease has demonstrated rapid absorption indicatingpotential for development as an oral therapy. The drug, NV-52, is an anti-inflammatory compound developed by Australianpharmaceutical company, Novogen Limited (Nasdaq: NVGN) (Australia: NRT). [click link for full article]Original post by It’s My Life, People
No comments